The Oncosearch | Oncotarget

Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach Research Paper

Zhiguang Xiao, Bianca Sperl, Silvia GÃ¤rtner, Tatiana Nedelko, Elvira Stacher-Priehse, Axel Ullrich, Pjotr G. Knyazev

Published Apr 2, 2019 · Vol. 10, No. 26 · pp. 2546-2560

ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Priority Research Paper

Aaditya Khatri, Jing Jin Gu, Courtney M. McKernan, Xia Xu, Ann Marie Pendergast

Published Mar 8, 2019 · Vol. 10, No. 20 · pp. 1874-1886

An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinoma Research Paper

Kevin B. Givechian, Chad Garner, Steve Benz, Bing Song, Shahrooz Rabizadeh, Patrick Soon-Shiong

Published Mar 5, 2019 · Vol. 10, No. 19 · pp. 1840-1849

Transforming growth factor Î²-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer Research Paper

Edna Gordian, Eric A. Welsh, Nicholas Gimbrone, Erin M. Siegel, David Shibata, Ben C. Creelan, William Douglas Cress, Steven A. Eschrich, Eric B. Haura, Teresita MuÃ±oz-Antonia

Published Jan 25, 2019 · Vol. 10, No. 8 · pp. 810-824

Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer Research Paper

Manolo D'Arcangelo, Armida D'Incecco, Claudia Ligorio, Stefania Damiani, Maurizio Puccetti, Sara Bravaccini, Luigi Terracciano, Chiara Bennati, Gabriele Minuti, Silvia Vecchiarelli, Lorenza Landi, Marina Milesi, Alberto Meroni, Sara Ravaioli, Maria Maddalena Tumedei, Matteo Incarbone, Federico Cappuzzo

Published Jan 15, 2019 · Vol. 10, No. 5 · pp. 561-572

Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis Meta-Analysis

Luigi Cavanna, Chiara Citterio, Elena Orlandi

Published Jan 4, 2019 · Vol. 10, No. 2 · pp. 209-215

Targeted therapies for advanced non-small cell lung cancer Review

Xiaojuan Ai, Xialing Guo, Jun Wang, Andreea L. Stancu, Patrick M.N. Joslin, Dianzheng Zhang, Shudong Zhu

Published Dec 25, 2018 · Vol. 9, No. 101 · pp. 37589-37607

Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer Research Paper

Takuya Shintani, Kazuma Higashisaka, Makiko Maeda, Masaya Hamada, Ryosuke Tsuji, Koudai Kurihara, Yuri Kashiwagi, Atsuhiro Sato, Masanori Obana, Ayaha Yamamoto, Keisuke Kawasaki, Ying Lin, Takashi Kijima, Yuhei Kinehara, Yoshihiro Miwa, Shinichiro Maeda, Eiichi Morii, Atsushi Kumanogoh, Yasuo Tsutsumi, Izumi Nagatomo, Yasushi Fujio

Published Dec 25, 2018 · Vol. 9, No. 101 · pp. 37520-37533

CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibition Priority Research Paper

Priya K. Gopalan, Andres Gordillo Villegas, Chunxia Cao, Mary Pinder-Schenck, Alberto Chiappori, Wei Hou, Maria Zajac-Kaye, Alison M. Ivey, Frederic J. Kaye

Published Dec 21, 2018 · Vol. 9, No. 100 · pp. 37352-37366

EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR Research Paper

Jordan Madic, CÃ©cile Jovelet, Julien Lopez, Barbara AndrÃ©, Jean Fatien, Isabelle Miran, AurÃ©lie HonorÃ©, Laura Mezquita, Benjamin Besse, Ludovic Lacroix, Magali Droniou

Published Dec 21, 2018 · Vol. 9, No. 100 · pp. 37393-37406

STAT1 deficiency supports PD-1/PD-L1 signaling resulting in dysfunctional TNFÎ± mediated immune responses in a model of NSCLC Research Paper

Juliane Friedrich, Lisanne Heim, Denis I. Trufa, Horia Sirbu, Ralf J. Rieker, Mircea T. Chiriac, Susetta Finotto

Published Dec 14, 2018 · Vol. 9, No. 98 · pp. 37157-37172

Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells Research Paper

Valentina Flamini, Ed Dudley, Wen G. Jiang, Yuxin Cui

Published Nov 23, 2018 · Vol. 9, No. 92 · pp. 36474-36491

Targeted next-generation sequencing reveals recurrence-associated genomic alterations in early-stage non-small cell lung cancer Research Paper

William C.S. Cho, Kien Thiam Tan, Victor W.S. Ma, Jacky Y.C. Li, Roger K.C. Ngan, Wah Cheuk, Timothy T.C. Yip, Yi-Ting Yang, Shu-Jen Chen

Published Nov 20, 2018 · Vol. 9, No. 91 · pp. 36344-36357

Anticancer activity of 2â€²-hydroxyflavanone towards lung cancer Research Paper

Sanjay Awasthi, Sharad S. Singhal, Jyotsana Singhal, Lokesh Nagaprashantha, Hongzhi Li, Yate-Ching Yuan, Zheng Liu, David Berz, Henry Igid, William C. Green, Lukman Tijani, Vijay Tonk, Aditya Rajan, Yogesh Awasthi, Sharda P. Singh

Published Nov 16, 2018 · Vol. 9, No. 90 · pp. 36202-36219

Clinical associations of mucin 1 in human lung cancer and precancerous lesions Research Paper

Andreas Saltos, Farah Khalil, Michelle Smith, Jiannong Li, Michael Schell, Scott J. Antonia, Jhanelle E. Gray

Published Nov 2, 2018 · Vol. 9, No. 86 · pp. 35666-35675

Distinct lung cancer subtypes associate to distinct drivers of tumor progression Research Paper

Valeria Relli, Marco Trerotola, Emanuela Guerra, Saverio Alberti

Published Oct 30, 2018 · Vol. 9, No. 85 · pp. 35528-35540

Systematic review and meta-analysis of third-line salvage therapy for the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials Meta-Analysis

Nan Zhang, Nan Guo, Liang Tian, Zhigang Miao

Published Oct 23, 2018 · Vol. 9, No. 83 · pp. 35439-35447

Making cytology specimens solid materials for testing predictive marker of immunotherapy in NSCLC Editorial

Hangjun Wang, Alan Spatz

Published Oct 16, 2018 · Vol. 9, No. 84 · pp. 35472-35473

Brain metastases in ALK-positive NSCLC â€“ time to adjust current treatment algorithms Review

Frank Griesinger, Julia Roeper, Christoph PÃ¶ttgen, Kay C. Willborn, Wilfried E.E. Eberhardt

Published Oct 12, 2018 · Vol. 9, No. 80 · pp. 35181-35194

Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer Research Paper

Dennis Ruder, Vassiliki Papadimitrakopoulou, Kazuhiko Shien, Carmen Behrens, Neda Kalhor, Huiqin Chen, Li Shen, J. Jack Lee, Waun Ki Hong, Ximing Tang, Luc Girard, John D. Minna, Lixia Diao, Jing Wang, Barbara Mino, Pamela Villalobos, Jaime Rodriguez-Canales, Nana E. Hanson, James Sun, Vincent Miller, Joel Greenbowe, Garrett Frampton, Roy S. Herbst, Veera Baladandayuthapani, Ignacio I. Wistuba, Julie G. Izzo

Published Sep 21, 2018 · Vol. 9, No. 74 · pp. 33995-34008

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach Research Paper

ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Priority Research Paper

An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinoma Research Paper

Transforming growth factor Î²-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer Research Paper

Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer Research Paper

Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis Meta-Analysis

Targeted therapies for advanced non-small cell lung cancer Review

Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer Research Paper

CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibition Priority Research Paper

EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR Research Paper

STAT1 deficiency supports PD-1/PD-L1 signaling resulting in dysfunctional TNFÎ± mediated immune responses in a model of NSCLC Research Paper

Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells Research Paper

Targeted next-generation sequencing reveals recurrence-associated genomic alterations in early-stage non-small cell lung cancer Research Paper

Anticancer activity of 2â€²-hydroxyflavanone towards lung cancer Research Paper

Clinical associations of mucin 1 in human lung cancer and precancerous lesions Research Paper

Distinct lung cancer subtypes associate to distinct drivers of tumor progression Research Paper

Systematic review and meta-analysis of third-line salvage therapy for the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials Meta-Analysis

Making cytology specimens solid materials for testing predictive marker of immunotherapy in NSCLC Editorial

Brain metastases in ALK-positive NSCLC â€“ time to adjust current treatment algorithms Review

Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach Research Paper

ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Priority Research Paper

An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinoma Research Paper

Transforming growth factor Î²-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer Research Paper

Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer Research Paper

Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis Meta-Analysis

Targeted therapies for advanced non-small cell lung cancer Review

Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer Research Paper

CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibition Priority Research Paper

EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR Research Paper

STAT1 deficiency supports PD-1/PD-L1 signaling resulting in dysfunctional TNFÎ± mediated immune responses in a model of NSCLC Research Paper

Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells Research Paper

Targeted next-generation sequencing reveals recurrence-associated genomic alterations in early-stage non-small cell lung cancer Research Paper

Anticancer activity of 2â€²-hydroxyflavanone towards lung cancer Research Paper

Clinical associations of mucin 1 in human lung cancer and precancerous lesions Research Paper

Distinct lung cancer subtypes associate to distinct drivers of tumor progression Research Paper

Systematic review and meta-analysis of third-line salvage therapy for the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials Meta-Analysis

Making cytology specimens solid materials for testing predictive marker of immunotherapy in NSCLC Editorial

Brain metastases in ALK-positive NSCLC â€“ time to adjust current treatment algorithms Review

Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer Research Paper